Roth Capital Issues Optimistic Outlook for CVE:HIV Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities researchers at Roth Capital boosted their FY2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a research note issued to investors on Wednesday, January 8th. Roth Capital analyst D. Aftahi now expects that the company will post earnings of ($0.53) per share for the year, up from their previous estimate of ($0.54). Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, Q1 2026 earnings at ($0.09) EPS, Q3 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.16) EPS and FY2028 earnings at ($0.09) EPS.

HIV has been the subject of a number of other research reports. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Four research analysts have rated the stock with a strong buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.